Mirati Therapeutics Inc Mirati Therapeutics Inc COM

Mirati Therapeutics Inc Mirati Therapeutics Inc COM is a security (CUSIP 60468T105) tracked across SEC portfolio filings. 3 registered fund positions totaling $26.5M via N-PORT as of 2021-02-28.

Summary

Top fund holders (N-PORT)

FundRegistrantValue% of fund
Touchstone Institutional Funds Trust-Touchstone Sands Capital Institutional Growth FundTouchstone Institutional Funds Trust$22.7M97.86%
UBS U.S. EQUITY ALPHA RELATIONSHIP FUNDUBS RELATIONSHIP FUNDS$2.1M69.30%
Small Cap Growth FundVALIC Co II$1.6M53.66%

More